Avanos Medical, Inc.
AVNS
$24.96
$0.000.00%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 80.66% | 81.41% | -3,086.62% | -4,163.16% | -557.44% |
| Total Depreciation and Amortization | -9.61% | -14.51% | -12.64% | 23.98% | 27.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.40% | -78.54% | 4,925.51% | 7,390.77% | 511.70% |
| Change in Net Operating Assets | -128.21% | -42.29% | 355.97% | 341.33% | 251.09% |
| Cash from Operations | -72.69% | -25.82% | 88.11% | 84.09% | 330.77% |
| Capital Expenditure | -43.14% | -77.53% | -56.08% | -60.38% | -45.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -1,247.62% | -- | -- |
| Divestitures | -- | -- | -102.31% | -100.00% | -102.31% |
| Other Investing Activities | 50.41% | 48.45% | 38.89% | -880.95% | -- |
| Cash from Investing | -71.10% | -120.36% | -200.49% | -273.14% | -246.61% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | 86.44% | 35.82% | 51.75% | 36.01% | 36.83% |
| Issuance of Common Stock | -30.00% | -36.36% | -36.36% | 100.00% | 100.00% |
| Repurchase of Common Stock | 59.32% | 74.22% | 83.77% | 83.16% | 67.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 72.95% | 72.95% |
| Cash from Financing | 85.68% | 24.64% | 54.77% | -2.71% | -6.46% |
| Foreign Exchange rate Adjustments | 300.00% | 221.95% | -88.24% | 2,400.00% | -266.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -248.11% | -189.50% | -2.21% | -118.27% | 206.53% |